Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder
- PMID: 29569150
- DOI: 10.1007/s11011-018-0206-6
Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder
Abstract
Autism spectrum disorder (ASD) is a multifactorial disorder caused by an interaction between environmental risk factors and a genetic background. It is characterized by impairment in communication, social interaction, repetitive behavior, and sensory processing. The etiology of ASD is still not fully understood, and the role of neuroinflammation in autism behaviors needs to be further investigated. The aim of the present study was to test the possible association between prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-1 (mPGES-1), prostaglandin PGE2 EP2 receptors and nuclear kappa B (NF-κB) and the severity of cognitive disorders, social impairment, and sensory dysfunction. PGE2, COX-2, mPGES-1, PGE2-EP2 receptors and NF-κB as biochemical parameters related to neuroinflammation were determined in the plasma of 47 Saudi male patients with ASD, categorized as mild to moderate and severe as indicated by the Childhood Autism Rating Scale (CARS) or the Social Responsiveness Scale (SRS) or the Short Sensory Profile (SSP) and compared to 46 neurotypical controls. The data indicated that ASD patients have remarkably higher levels of the measured parameters compared to neurotypical controls, except for EP2 receptors that showed an opposite trend. While the measured parameter did not correlate with the severity of social and cognitive dysfunction, PGE2, COX-2, and mPGES-1 were remarkably associated with the dysfunction in sensory processing. NF-κB was significantly increased in relation to age. Based on the discussed data, the positive correlation between PGE2, COX-2, and mPGES-1 confirm the role of PGE2 pathway and neuroinflammation in the etiology of ASD, and the possibility of using PGE2, COX-2 and mPGES-1 as biomarkers of autism severity. NF-κB as inflammatory inducer showed an elevated level in plasma of ASD individuals. Receiver operating characteristic analysis together with predictiveness diagrams proved that the measured parameters could be used as predictive biomarkers of biochemical correlates to ASD.
Keywords: Autism; Childhood autism rating scale; Cyclooxygenase-2, microsomal prostaglandin E synthase-1, neuroinflammation; NF-κB: Nuclear factor kappa B, PGE2: prostaglandin E 2, short sensory profile; Social responsiveness scale.
Similar articles
-
Identification of Biomarkers of Impaired Sensory Profiles among Autistic Patients.PLoS One. 2016 Nov 8;11(11):e0164153. doi: 10.1371/journal.pone.0164153. eCollection 2016. PLoS One. 2016. PMID: 27824861 Free PMC article.
-
Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values.Lipids Health Dis. 2021 Nov 6;20(1):155. doi: 10.1186/s12944-021-01578-7. Lipids Health Dis. 2021. PMID: 34742290 Free PMC article.
-
Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder.Metab Brain Dis. 2018 Jun;33(3):843-854. doi: 10.1007/s11011-018-0186-6. Epub 2018 Feb 3. Metab Brain Dis. 2018. PMID: 29397522
-
The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders.Exp Biol Med (Maywood). 2023 May;248(9):811-819. doi: 10.1177/15353702231179926. Epub 2023 Jul 29. Exp Biol Med (Maywood). 2023. PMID: 37515545 Free PMC article. Review.
-
The Role of mPGES-1 in Inflammatory Brain Diseases.Biol Pharm Bull. 2017;40(5):557-563. doi: 10.1248/bpb.b16-01026. Biol Pharm Bull. 2017. PMID: 28458341 Review.
Cited by
-
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder.J Transl Med. 2019 Oct 2;17(1):332. doi: 10.1186/s12967-019-2076-z. J Transl Med. 2019. PMID: 31578139 Free PMC article.
-
The Role of Lipidomics in Autism Spectrum Disorder.Mol Diagn Ther. 2020 Feb;24(1):31-48. doi: 10.1007/s40291-019-00430-0. Mol Diagn Ther. 2020. PMID: 31691195 Review.
-
CTRP3 as a novel biomarker in the plasma of Saudi children with autism.PeerJ. 2022 Jan 11;10:e12630. doi: 10.7717/peerj.12630. eCollection 2022. PeerJ. 2022. PMID: 35047232 Free PMC article.
-
Untargeted urine metabolomics and machine learning provide potential metabolic signatures in children with autism spectrum disorder.Front Psychiatry. 2024 Feb 20;15:1261617. doi: 10.3389/fpsyt.2024.1261617. eCollection 2024. Front Psychiatry. 2024. PMID: 38445087 Free PMC article.
-
Environmental influence on neurodevelopmental disorders: Potential association of heavy metal exposure and autism.J Trace Elem Med Biol. 2020 Dec;62:126638. doi: 10.1016/j.jtemb.2020.126638. Epub 2020 Aug 29. J Trace Elem Med Biol. 2020. PMID: 32891009 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials